GSK’s new data underscore important responses with momelotinib for myelofibrosis patients
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
The use of procalcitonin testing for sepsis management is highest in the US
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
The service includes full fertility care benefits, including egg and embryo freezing options to employees
The new eye hospital in Vashi is ASG’s second in the Mumbai Metropolitan Region (MMR) and the sixth in Maharashtra
Expanded capacity in Nansha, China will support mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial production
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities
Subscribe To Our Newsletter & Stay Updated